These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25241292)

  • 1. Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole.
    Martínez C; Andreu I; Amo G; Miranda MA; Esguevillas G; Torres MJ; Blanca-López N; Blanca M; García-Martín E; Agúndez JA
    Biochem Pharmacol; 2014 Dec; 92(3):457-66. PubMed ID: 25241292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis.
    García-Martín E; Esguevillas G; Blanca-López N; García-Menaya J; Blanca M; Amo G; Canto G; Martínez C; Cordobés C; Agúndez JA
    Pharmacogenet Genomics; 2015 Sep; 25(9):462-4. PubMed ID: 26111152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.
    Radulovic I; Dogan B; Dohna-Schwake C; Schündeln MM; Siffert W; Möhlendick B
    Pharmacogenet Genomics; 2021 Aug; 31(6):140-143. PubMed ID: 33675325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
    Saldaña-Cruz AM; León-Moreno LC; Sánchez-Corona J; Santiago DA; Mendoza-Carrera F; Castro-Martínez XH; García-Zapién AG; Morán-Moguel MC; Flores-Martínez SE
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study.
    Adole PS; Kharbanda PS; Sharma S
    Indian J Med Res; 2016 May; 143(5):581-90. PubMed ID: 27488001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
    Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
    Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase polymorphism among northern Sudanese.
    Al-Yahyaee S; Gaffar U; Al-Ameri MM; Qureshi M; Zadjali F; Ali BH; Bayoumi R
    Hum Biol; 2007 Aug; 79(4):445-52. PubMed ID: 18075007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.
    Balhara A; Singh S
    Pharm Res; 2021 Sep; 38(9):1485-1496. PubMed ID: 34518943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
    Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
    Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
    Hiratsuka M
    Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfamethoxazole-trimethoprim-induced liver injury and genetic polymorphisms of NAT2 and CYP2C9 in Taiwan.
    Huang YS; Tseng SY; Chang TE; Perng CL; Huang YH
    Pharmacogenet Genomics; 2021 Dec; 31(9):200-206. PubMed ID: 34149005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2.
    Bendaly J; Zhao S; Neale JR; Metry KJ; Doll MA; States JC; Pierce WM; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1503-9. PubMed ID: 17627018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytochrome P450 and NAT2 polymorphisms and drug metabolism in DOTS].
    Castillejos-López Mde J; García-Sancho MC; Quiñones-Falconi F; Pérez-Padilla JR
    Rev Invest Clin; 2008; 60(1):47-57. PubMed ID: 18589587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.